| Michelle Guarino Judice, RPH | |
|
2640 North Dr, Abbeville, LA 70510-4043 | |
| (337) 893-6304 | |
| (337) 893-6306 |
| Full Name | Michelle Guarino Judice |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2640 North Dr, Abbeville, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942570692 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15909 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Guarino Judice, RPH 218 N Hollingsworth Dr, Abbeville, LA 70510-3649 Ph: (337) 893-1612 | Michelle Guarino Judice, RPH 2640 North Dr, Abbeville, LA 70510-4043 Ph: (337) 893-6304 |
News Archive
Anchor Therapeutics today announced an initial closing of $10 million in a Series B financing. The investment is being led by current investors TVM Capital, HealthCare Ventures and the Novartis Option Fund. The company is in continuing discussions with additional investors interested in joining the Series B. Anchor Therapeutics is focused on developing peptide drug candidates, called pepducins, that modulate G protein coupled receptors (GPCRs), particularly those historically difficult to target using standard pharmaceutical approaches.
The antibiotic amoxicillin, that doctors typically prescribe for common lower respiratory tract infections (LRTI) such as cough and bronchitis, is no more effective at relieving symptoms than the use of no medication, even in older patients. The findings from the largest randomised placebo controlled trial of antibiotics for acute uncomplicated LRTI to date are published Online First in The Lancet Infectious Diseases.
Kaiser Health News staff writer Mary Agnes Carey reports: "By Sept. 23, the six month anniversary of the enactment of the health overhaul, many of the law's provisions will be in effect.
Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) for JANUVIA® tablets and JANUMET® tablets recommending their use as add-on to insulin for the treatment of type 2 diabetes.
› Verified 4 days ago
Marisa Rogers, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2509 Charity St, Abbeville, LA 70510 Phone: 337-893-2131 | |
Mr. Kyle Romero, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-893-9686 | |
Valerie G Champagne, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3009 Broussard St, Abbeville, LA 70510 Phone: 337-258-5716 | |
Dr. Ryan Lassabe, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-893-9686 Fax: 337-898-9328 | |
Mark Mouton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3005 Charity St, Abbeville, LA 70510 Phone: 337-893-4077 Fax: 337-893-4079 | |
Dr. Aaron Alexander Head, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3005 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-893-4077 Fax: 337-893-4079 | |
Dr. Sarah Le, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2201 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-898-1350 |